THE Therapeutic Goods
Administration has advised that a
range of fat loss products sold as
Albuterex Xtreme, Albutarax
Xtreme and Albutarex Femme
Formula pose a “serious health
risk” to Australian consumers.
TGA testing has found that
batches of the products contain
prescription-only theophylline as
well as extremely high levels of
caffeine which combined could
have a “dangerous stimulant effect”
leading to life-threatening heart
rhythms and seizures.The above article was sent to subscribers in Pharmacy Daily's issue from 06 Feb 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 06 Feb 13
THE Pharmaceutical Society of Australia (PSA) awarded Brooke Shelly the prestigious 2024 PSA MIMS Credentialed Pharmacist of the Year award last Fri at the Credentialed Pharmacist Conference (CPC24) (PD breaking news).
THE Pharmaceutical Society of Australia (PSA) has unveiled a comprehensive membership package designed to provide robust support for credentialed pharmacists throughout their professional journey.
MEDICAL research produces better outcomes when people with lived experience are involved in the process, according to Breast Cancer Network Australia (BCNA).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.